Methylthiouracil

From Wikipedia, the free encyclopedia

Methylthiouracil
Systematic (IUPAC) name
6-methyl-2-sulfanylidene-1H-pyrimidin-4-one
Identifiers
CAS number 56-04-2
ATC code H03BA01
PubChem 667493
Chemical data
Formula C5H6N2OS 
Mol. mass 142.18 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Methylthiouracil is an antithyroid preparation. It is a thioamide, closely related to propylthiouracil.

Methylthiouracil is not used clinically in the United States, it has a similar mechanism of action and side effect to that of propylthiouricil.

The drug acts to decrease the formation of stored thyroid hormone, as thyroglobulin in the thyroid gland.

The clinical effects of the drug to treat the hyperthyroid state can have a lag peroid of up to two weeks, depending on the stores of thyroglobulin and other factors.

Like with any drug a wide variety of side effects can occur, but four topics should be kept in mind and the patient informed:

Agranulocytosis - develops rapidly, sore throat and fever are hallmark symptoms. Can be fatal if drug is not discontinued promptly.

Allergic Skin reactions the most dangerous of which is Exfoliative Dermatitis, it rapidly can get out of control, notify the physician should a skin eruption occur.

Hepatitis - yellowing of the skin, nausea, yellowing of the whites of the eyes, flu like symptoms.

Thombocytopenia - unusual brusing or bleeding.

Source: Goodman and Gillman's Pharmacological Basis of Therapeutics, 6th edition, and Facts and Comparisons.

see link on discussion of Hyperthyrodism: http://www.merck.com/mmpe/sec12/ch152/ch152e.html#S12_CH152_T002